301033.SZ · 迈普医学
China A-shares · RS rating 19 · As of 2026-10-14
| Price | 49.02 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 28 / 34 / 19 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 17 / 18 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +42.2% |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $537.6M |